nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—Urine phosphorus increased—Ifosfamide—testicular cancer	0.17	0.17	CcSEcCtD
Diclofenamide—Urine phosphate increased—Ifosfamide—testicular cancer	0.17	0.17	CcSEcCtD
Diclofenamide—Hepatic insufficiency—Methotrexate—testicular cancer	0.025	0.025	CcSEcCtD
Diclofenamide—Metabolic acidosis—Ifosfamide—testicular cancer	0.0206	0.0206	CcSEcCtD
Diclofenamide—Digestion impaired—Chlorambucil—testicular cancer	0.0185	0.0185	CcSEcCtD
Diclofenamide—Metabolic acidosis—Etoposide—testicular cancer	0.0163	0.0163	CcSEcCtD
Diclofenamide—Eruption—Dactinomycin—testicular cancer	0.0145	0.0145	CcSEcCtD
Diclofenamide—Hyperuricaemia—Chlorambucil—testicular cancer	0.0133	0.0133	CcSEcCtD
Diclofenamide—Blood uric acid increased—Chlorambucil—testicular cancer	0.0126	0.0126	CcSEcCtD
Diclofenamide—Ataxia—Chlorambucil—testicular cancer	0.00842	0.00842	CcSEcCtD
Diclofenamide—Disorientation—Bleomycin—testicular cancer	0.00775	0.00775	CcSEcCtD
Diclofenamide—Hyperuricaemia—Cisplatin—testicular cancer	0.00758	0.00758	CcSEcCtD
Diclofenamide—Hepatic failure—Dactinomycin—testicular cancer	0.00719	0.00719	CcSEcCtD
Diclofenamide—Blood uric acid increased—Cisplatin—testicular cancer	0.00716	0.00716	CcSEcCtD
Diclofenamide—Hyperuricaemia—Etoposide—testicular cancer	0.00695	0.00695	CcSEcCtD
Diclofenamide—Body temperature increased—Carboplatin—testicular cancer	0.00676	0.00676	CcSEcCtD
Diclofenamide—Disorientation—Ifosfamide—testicular cancer	0.00662	0.00662	CcSEcCtD
Diclofenamide—Hepatic failure—Ifosfamide—testicular cancer	0.00659	0.00659	CcSEcCtD
Diclofenamide—Blood uric acid increased—Etoposide—testicular cancer	0.00656	0.00656	CcSEcCtD
Diclofenamide—Eruption—Methotrexate—testicular cancer	0.00628	0.00628	CcSEcCtD
Diclofenamide—Agranulocytosis—Vinblastine—testicular cancer	0.0059	0.0059	CcSEcCtD
Diclofenamide—Eruption—Epirubicin—testicular cancer	0.00587	0.00587	CcSEcCtD
Diclofenamide—Eruption—Doxorubicin—testicular cancer	0.00543	0.00543	CcSEcCtD
Diclofenamide—Weight decreased—Bleomycin—testicular cancer	0.00542	0.00542	CcSEcCtD
Diclofenamide—Hypokalaemia—Ifosfamide—testicular cancer	0.00539	0.00539	CcSEcCtD
Diclofenamide—Tremor—Chlorambucil—testicular cancer	0.00505	0.00505	CcSEcCtD
Diclofenamide—Leukopenia—Chlorambucil—testicular cancer	0.00483	0.00483	CcSEcCtD
Diclofenamide—Pollakiuria—Ifosfamide—testicular cancer	0.00473	0.00473	CcSEcCtD
Diclofenamide—Agranulocytosis—Dactinomycin—testicular cancer	0.00465	0.00465	CcSEcCtD
Diclofenamide—Hypokalaemia—Cisplatin—testicular cancer	0.00465	0.00465	CcSEcCtD
Diclofenamide—Confusional state—Chlorambucil—testicular cancer	0.00444	0.00444	CcSEcCtD
Diclofenamide—Leukopenia—Vinblastine—testicular cancer	0.00442	0.00442	CcSEcCtD
Diclofenamide—Thrombocytopenia—Chlorambucil—testicular cancer	0.00431	0.00431	CcSEcCtD
Diclofenamide—Agranulocytosis—Ifosfamide—testicular cancer	0.00426	0.00426	CcSEcCtD
Diclofenamide—Anorexia—Chlorambucil—testicular cancer	0.0042	0.0042	CcSEcCtD
Diclofenamide—Hyperuricaemia—Methotrexate—testicular cancer	0.00416	0.00416	CcSEcCtD
Diclofenamide—Thrombocytopenia—Vinblastine—testicular cancer	0.00395	0.00395	CcSEcCtD
Diclofenamide—Blood uric acid increased—Methotrexate—testicular cancer	0.00393	0.00393	CcSEcCtD
Diclofenamide—Hyperuricaemia—Epirubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Diclofenamide—Dyspepsia—Chlorambucil—testicular cancer	0.00387	0.00387	CcSEcCtD
Diclofenamide—Anorexia—Vinblastine—testicular cancer	0.00384	0.00384	CcSEcCtD
Diclofenamide—Decreased appetite—Chlorambucil—testicular cancer	0.00383	0.00383	CcSEcCtD
Diclofenamide—Tinnitus—Ifosfamide—testicular cancer	0.00382	0.00382	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.0038	0.0038	CcSEcCtD
Diclofenamide—Fatigue—Chlorambucil—testicular cancer	0.00379	0.00379	CcSEcCtD
Diclofenamide—Leukopenia—Bleomycin—testicular cancer	0.00374	0.00374	CcSEcCtD
Diclofenamide—Blood uric acid increased—Epirubicin—testicular cancer	0.00368	0.00368	CcSEcCtD
Diclofenamide—Feeling abnormal—Chlorambucil—testicular cancer	0.00363	0.00363	CcSEcCtD
Diclofenamide—Paraesthesia—Vinblastine—testicular cancer	0.00362	0.00362	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—testicular cancer	0.0036	0.0036	CcSEcCtD
Diclofenamide—Decreased appetite—Vinblastine—testicular cancer	0.00351	0.00351	CcSEcCtD
Diclofenamide—Leukopenia—Dactinomycin—testicular cancer	0.00348	0.00348	CcSEcCtD
Diclofenamide—Body temperature increased—Chlorambucil—testicular cancer	0.00348	0.00348	CcSEcCtD
Diclofenamide—Constipation—Vinblastine—testicular cancer	0.00345	0.00345	CcSEcCtD
Diclofenamide—Confusional state—Bleomycin—testicular cancer	0.00343	0.00343	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—testicular cancer	0.0034	0.0034	CcSEcCtD
Diclofenamide—Agranulocytosis—Etoposide—testicular cancer	0.00336	0.00336	CcSEcCtD
Diclofenamide—Thrombocytopenia—Bleomycin—testicular cancer	0.00334	0.00334	CcSEcCtD
Diclofenamide—Feeling abnormal—Vinblastine—testicular cancer	0.00332	0.00332	CcSEcCtD
Diclofenamide—Tinnitus—Cisplatin—testicular cancer	0.00329	0.00329	CcSEcCtD
Diclofenamide—Anorexia—Bleomycin—testicular cancer	0.00325	0.00325	CcSEcCtD
Diclofenamide—Leukopenia—Ifosfamide—testicular cancer	0.00319	0.00319	CcSEcCtD
Diclofenamide—Asthenia—Chlorambucil—testicular cancer	0.00316	0.00316	CcSEcCtD
Diclofenamide—Hepatic failure—Methotrexate—testicular cancer	0.00312	0.00312	CcSEcCtD
Diclofenamide—Pruritus—Chlorambucil—testicular cancer	0.00311	0.00311	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dactinomycin—testicular cancer	0.00311	0.00311	CcSEcCtD
Diclofenamide—Paraesthesia—Bleomycin—testicular cancer	0.00306	0.00306	CcSEcCtD
Diclofenamide—Anorexia—Dactinomycin—testicular cancer	0.00303	0.00303	CcSEcCtD
Diclofenamide—Decreased appetite—Bleomycin—testicular cancer	0.00296	0.00296	CcSEcCtD
Diclofenamide—Confusional state—Ifosfamide—testicular cancer	0.00294	0.00294	CcSEcCtD
Diclofenamide—Hepatic failure—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Diclofenamide—Asthenia—Vinblastine—testicular cancer	0.00289	0.00289	CcSEcCtD
Diclofenamide—Tremor—Cisplatin—testicular cancer	0.00288	0.00288	CcSEcCtD
Diclofenamide—Thrombocytopenia—Ifosfamide—testicular cancer	0.00285	0.00285	CcSEcCtD
Diclofenamide—Feeling abnormal—Bleomycin—testicular cancer	0.00281	0.00281	CcSEcCtD
Diclofenamide—Vomiting—Chlorambucil—testicular cancer	0.0028	0.0028	CcSEcCtD
Diclofenamide—Anorexia—Ifosfamide—testicular cancer	0.00278	0.00278	CcSEcCtD
Diclofenamide—Decreased appetite—Dactinomycin—testicular cancer	0.00276	0.00276	CcSEcCtD
Diclofenamide—Leukopenia—Cisplatin—testicular cancer	0.00275	0.00275	CcSEcCtD
Diclofenamide—Fatigue—Dactinomycin—testicular cancer	0.00274	0.00274	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Diclofenamide—Body temperature increased—Bleomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Diclofenamide—Dizziness—Vinblastine—testicular cancer	0.00267	0.00267	CcSEcCtD
Diclofenamide—Ataxia—Methotrexate—testicular cancer	0.00264	0.00264	CcSEcCtD
Diclofenamide—Feeling abnormal—Dactinomycin—testicular cancer	0.00262	0.00262	CcSEcCtD
Diclofenamide—Nausea—Chlorambucil—testicular cancer	0.00261	0.00261	CcSEcCtD
Diclofenamide—Paraesthesia—Ifosfamide—testicular cancer	0.00261	0.00261	CcSEcCtD
Diclofenamide—Somnolence—Ifosfamide—testicular cancer	0.00259	0.00259	CcSEcCtD
Diclofenamide—Vomiting—Vinblastine—testicular cancer	0.00256	0.00256	CcSEcCtD
Diclofenamide—Decreased appetite—Ifosfamide—testicular cancer	0.00253	0.00253	CcSEcCtD
Diclofenamide—Headache—Vinblastine—testicular cancer	0.00253	0.00253	CcSEcCtD
Diclofenamide—Leukopenia—Etoposide—testicular cancer	0.00252	0.00252	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00251	0.00251	CcSEcCtD
Diclofenamide—Body temperature increased—Dactinomycin—testicular cancer	0.00251	0.00251	CcSEcCtD
Diclofenamide—Fatigue—Ifosfamide—testicular cancer	0.00251	0.00251	CcSEcCtD
Diclofenamide—Constipation—Ifosfamide—testicular cancer	0.00249	0.00249	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Diclofenamide—Thrombocytopenia—Cisplatin—testicular cancer	0.00246	0.00246	CcSEcCtD
Diclofenamide—Asthenia—Bleomycin—testicular cancer	0.00244	0.00244	CcSEcCtD
Diclofenamide—Pruritus—Bleomycin—testicular cancer	0.00241	0.00241	CcSEcCtD
Diclofenamide—Feeling abnormal—Ifosfamide—testicular cancer	0.0024	0.0024	CcSEcCtD
Diclofenamide—Nausea—Vinblastine—testicular cancer	0.0024	0.0024	CcSEcCtD
Diclofenamide—Anorexia—Cisplatin—testicular cancer	0.00239	0.00239	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Diclofenamide—Confusional state—Etoposide—testicular cancer	0.00232	0.00232	CcSEcCtD
Diclofenamide—Body temperature increased—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Diclofenamide—Asthenia—Dactinomycin—testicular cancer	0.00228	0.00228	CcSEcCtD
Diclofenamide—Paraesthesia—Cisplatin—testicular cancer	0.00225	0.00225	CcSEcCtD
Diclofenamide—Thrombocytopenia—Etoposide—testicular cancer	0.00225	0.00225	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—testicular cancer	0.00219	0.00219	CcSEcCtD
Diclofenamide—Decreased appetite—Cisplatin—testicular cancer	0.00218	0.00218	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00217	0.00217	CcSEcCtD
Diclofenamide—Vomiting—Bleomycin—testicular cancer	0.00217	0.00217	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—testicular cancer	0.00216	0.00216	CcSEcCtD
Diclofenamide—Rash—Bleomycin—testicular cancer	0.00215	0.00215	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Diclofenamide—Asthenia—Ifosfamide—testicular cancer	0.00209	0.00209	CcSEcCtD
Diclofenamide—Feeling abnormal—Cisplatin—testicular cancer	0.00207	0.00207	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—testicular cancer	0.00206	0.00206	CcSEcCtD
Diclofenamide—Pruritus—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—testicular cancer	0.00204	0.00204	CcSEcCtD
Diclofenamide—Nausea—Bleomycin—testicular cancer	0.00202	0.00202	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Diclofenamide—Vomiting—Dactinomycin—testicular cancer	0.00202	0.00202	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—testicular cancer	0.00202	0.00202	CcSEcCtD
Diclofenamide—Rash—Dactinomycin—testicular cancer	0.002	0.002	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—testicular cancer	0.002	0.002	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Diclofenamide—Body temperature increased—Cisplatin—testicular cancer	0.00198	0.00198	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—testicular cancer	0.00198	0.00198	CcSEcCtD
Diclofenamide—Constipation—Etoposide—testicular cancer	0.00197	0.00197	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Diclofenamide—Dizziness—Ifosfamide—testicular cancer	0.00193	0.00193	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—testicular cancer	0.00189	0.00189	CcSEcCtD
Diclofenamide—Nausea—Dactinomycin—testicular cancer	0.00189	0.00189	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Diclofenamide—Vomiting—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Diclofenamide—Rash—Ifosfamide—testicular cancer	0.00184	0.00184	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Diclofenamide—Asthenia—Cisplatin—testicular cancer	0.0018	0.0018	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Diclofenamide—Nausea—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—testicular cancer	0.00165	0.00165	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Diclofenamide—Vomiting—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Diclofenamide—Rash—Cisplatin—testicular cancer	0.00158	0.00158	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Diclofenamide—Tension—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Diclofenamide—Nausea—Cisplatin—testicular cancer	0.00149	0.00149	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Diclofenamide—Rash—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Diclofenamide—Headache—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Diclofenamide—Confusional state—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Diclofenamide—Nausea—Etoposide—testicular cancer	0.00137	0.00137	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Diclofenamide—Paraesthesia—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Diclofenamide—Decreased appetite—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—testicular cancer	0.000988	0.000988	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000983	0.000983	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—testicular cancer	0.000974	0.000974	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—testicular cancer	0.000943	0.000943	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—testicular cancer	0.000925	0.000925	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—testicular cancer	0.000911	0.000911	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—testicular cancer	0.000876	0.000876	CcSEcCtD
Diclofenamide—Rash—Methotrexate—testicular cancer	0.000868	0.000868	CcSEcCtD
Diclofenamide—Headache—Methotrexate—testicular cancer	0.000863	0.000863	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—testicular cancer	0.000856	0.000856	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—testicular cancer	0.000818	0.000818	CcSEcCtD
Diclofenamide—Rash—Epirubicin—testicular cancer	0.000813	0.000813	CcSEcCtD
Diclofenamide—Headache—Epirubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
